VISIBLE
Helps VISIBLE for Advance diagnosis and treatment of coronary microvascular disease in women from under to over.
Wellcome LeapCooperative agreement
About
VISIBLE is a Wellcome Leap program co-funded with Pivotal Ventures and the British Heart Foundation. It focuses on coronary microvascular disease in women, a condition that current diagnostic pathways often miss, and it sets an unusually explicit target: move effective diagnosis and treatment from under 1 percent to over 80 percent.
The 2026 solicitation sat at $55 million. Applications were due …
BiotechMedtech
Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.